Rhythm Pharmaceuticals
The Director, Registry Operations at Rhythm oversees the development and management of patient registries for rare neuroendocrine diseases. The role involves strategic planning, coordination with stakeholders, and ensuring data integrity to support clinical research and evidence generation.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
31% above the average for this role
Director Global Evidence Generation Rare Disease
Novo Nordisk A/S
Global Health Economics & Outcomes Research (HEOR) Director
Ipsen
Sr. Director Evidence Generation
BridgeBio Pharma
Associate Director/ Director, Health Economics and Outcomes Research (HEOR) (Early Stage Pipeline)
iSi Environmental
Director, Real-World Evidence
Novartis
Registry Data Specialist
United Health Services